Patents by Inventor Gayle Stephenson

Gayle Stephenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100130684
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: December 15, 2009
    Publication date: May 27, 2010
    Applicant: Nektar Therapeutics
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Publication number: 20100120982
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: December 15, 2009
    Publication date: May 13, 2010
    Applicant: NEKTAR THERAPEUTICS
    Inventors: MARY J. BOSSARD, GAYLE STEPHENSON
  • Patent number: 7714114
    Abstract: Conjugates of an EPO moiety and one or more non-peptidic water-soluble polymers are provided. Typically, the non-peptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising such conjugates, methods of making conjugates, and methods of administering compositions comprising such conjugates to a patient.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: May 11, 2010
    Assignee: Nektar Therapeutics
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Publication number: 20100021481
    Abstract: Conjugates of an anti-TNF antibody and one or more nonpeptidic water soluble polymers are provided. Typically, the nonpeptidic water soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, and methods of administering compositions to a patient.
    Type: Application
    Filed: April 6, 2007
    Publication date: January 28, 2010
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Publication number: 20090280550
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: July 8, 2009
    Publication date: November 12, 2009
    Applicant: Nektar Therapeutics AL, Corporation
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Patent number: 7579444
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: August 25, 2009
    Assignee: Nektar Therapeutics AL, Corporation
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Publication number: 20080234193
    Abstract: The present invention provides von Willebrand Factor-polymer conjugates and Factor VIII-polymer conjugates, each having a releasable linkage. Methods of making conjugates, methods for administering conjugates, are also provided.
    Type: Application
    Filed: December 27, 2007
    Publication date: September 25, 2008
    Applicants: Nektar Therapeutics AL, Corporation, Baxter International Inc., Baxter Healthcare SA
    Inventors: Mary J. Bossard, Gayle Stephenson, Zhihao Fang, Harold Zappe, Stacy Mitchell, Ping Zhang, Friedrich Scheiflinger, Peter Turecek, Juergen Siekmann, Katalin Varadi, Herbert Gritsch
  • Publication number: 20080188414
    Abstract: The present invention provides Factor IX moiety-polymer conjugates having a releaseable linkage. Methods of making conjugates, methods for administering conjugates, are also provided.
    Type: Application
    Filed: December 27, 2007
    Publication date: August 7, 2008
    Applicant: Nektar Therapeutics AL, Corporation
    Inventors: Mary J. Bossard, Gayle Stephenson
  • Publication number: 20060182711
    Abstract: Conjugates of an EPO moiety and one or more non-peptidic water-soluble polymers are provided. Typically, the non-peptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising such conjugates, methods of making conjugates, and methods of administering compositions comprising such conjugates to a patient.
    Type: Application
    Filed: February 16, 2006
    Publication date: August 17, 2006
    Inventors: Mary Bossard, Gayle Stephenson
  • Publication number: 20060052302
    Abstract: Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
    Type: Application
    Filed: June 30, 2005
    Publication date: March 9, 2006
    Inventors: Mary Bossard, Gayle Stephenson